Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement
SM Grundy, JI Cleeman, SR Daniels, KA Donato… - Circulation, 2005 - ahajournals.org
strongly with insulin resistance. Excess upper body fat can accumulate either
intraperitoneally (visceral fat) or subcutaneously. Many investigators claim that excess …
intraperitoneally (visceral fat) or subcutaneously. Many investigators claim that excess …
Cardiovascular disease in the develo** world: prevalences, patterns, and the potential of early disease detection
Over the past decade or more, the prevalence of traditional risk factors for atherosclerotic
cardiovascular diseases has been increasing in the major populous countries of the …
cardiovascular diseases has been increasing in the major populous countries of the …
Predicting metabolic syndrome by obesity-and lipid-related indices in mid-aged and elderly Chinese: a population-based cross-sectional study
Y Li, J Gui, H Liu, L Guo, J Li, Y Lei, X Li… - Frontiers in …, 2023 - frontiersin.org
Objective To predict the optimal cut-off values for screening and predicting metabolic
syndrome (MetS) in a middle-aged and elderly Chinese population using 13 obesity and …
syndrome (MetS) in a middle-aged and elderly Chinese population using 13 obesity and …
Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US
ES Ford - Diabetes care, 2005 - diabetesjournals.org
OBJECTIVE—The International Diabetes Federation (IDF) has proposed a new definition of
the metabolic syndrome that emphasizes central adiposity as determined by ethnic group …
the metabolic syndrome that emphasizes central adiposity as determined by ethnic group …
Adipocyte fatty acid–binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome
Background: Adipocyte fatty acid–binding protein (A-FABP) is traditionally thought to be a
cytosolic fatty acid chaperone expressed in adipocytes. Mice with targeted disruption of the …
cytosolic fatty acid chaperone expressed in adipocytes. Mice with targeted disruption of the …
Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian …
B Hildrum, A Mykletun, T Hole, K Midthjell, AA Dahl - BMC public health, 2007 - Springer
Abstract Background The 2005 International Diabetes Federation (IDF) definition of the
metabolic syndrome was designed to be useful worldwide, but to date few prevalence …
metabolic syndrome was designed to be useful worldwide, but to date few prevalence …
Prevalence of the metabolic syndrome among Turkish adults
Objective: To determine prevalence of the metabolic syndrome (MS) in a sample
representing Turkish population using United States Adult Treatment Panel-3 guidelines …
representing Turkish population using United States Adult Treatment Panel-3 guidelines …
The metabolic syndrome—from insulin resistance to obesity and diabetes
EJ Gallagher, D LeRoith, E Karnieli - Endocrinology and metabolism clinics …, 2008 - Elsevier
In today's society with the escalating levels of obesity, diabetes, and cardiovascular disease,
the metabolic syndrome is receiving considerable attention and is the subject of much …
the metabolic syndrome is receiving considerable attention and is the subject of much …
Metabolic syndrome
The metabolic syndrome is a condition characterized by the co-existence of several major
risk factors for cardiovascular disease (CVD)–high blood pressure, hyperglycaemia, and …
risk factors for cardiovascular disease (CVD)–high blood pressure, hyperglycaemia, and …
Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES‐34)
Aim To compare the prevalence of metabolic syndrome (MS) using the World Health
Organisation (WHO), Adult Treatment Panel III (ATPIII) and International Diabetes …
Organisation (WHO), Adult Treatment Panel III (ATPIII) and International Diabetes …